{"id":6341,"date":"2015-07-23T12:12:54","date_gmt":"2015-07-23T12:12:54","guid":{"rendered":"\/?p=6341"},"modified":"2015-07-23T12:39:25","modified_gmt":"2015-07-23T12:39:25","slug":"tapimmune-inc-otcmktstpiv-down-in-double-digits","status":"publish","type":"post","link":"\/articles\/tapimmune-inc-otcmktstpiv-down-in-double-digits\/","title":{"rendered":"TapImmune Inc. (OTCMKTS:TPIV) Down in Double Digits"},"content":{"rendered":"\n

When it’s raining over at TapImmune Inc. (OTCMKTS:TPIV<\/a>), it seems it’s pouring. In yesterday’s session the stock slid in double digits once again. TPIV<\/a> had slipped down to $0.55 per share by the closing bell, another 14% down the chart, on its heaviest volume for the past two months.<\/p>\n

TPIV<\/a>‘s chart for the last few months is quite a sight. After increasing over 600% over the course of less than eight weeks, TPIV<\/a> is currently speeding back down, having dropped over 60% from its late June peak.<\/p>\n

The company’s price surge was sped along by a very optimistic news release. TPIV<\/a> announced very good immune response in female patients who were given a sequence of vaccine shots during the company’s Phase 1 trials. The day this news hit the wire was also the day the company peaked before starting its downhill blitz.<\/p>\n

It was more or less obvious TPIV<\/a> was going to pull back significantly. After its first march from $0.20 to $0.40 in May, TPIV<\/a> went back to normal trading ranges. However, its second and much bigger push up sent the stock far inside ‘overbought’ territory. TPIV<\/a> remained heavily overbought for almost a full month – an amazing feat on its own, and the correction was bound to happen.<\/p>\n

Of course, there is also the considerable incentive to simply cash out a good portion of your shares in any given company if it climbs up 600% and this too will hurt the price.<\/p>\n

There is also the matter with the company readjusting the exercise prices of a number of different warrants, and lowering them significantly by as much as 90% for the Series A and A-1 which had their exercise price slashed from $1.50 down to $0.10 per warrant. Curiously, this readjustment was announced in late May and investors who were buying TPIV<\/a> up to $1.51 per share already had access to this information.<\/p>\n","protected":false},"excerpt":{"rendered":"

When it’s raining over at TapImmune Inc. (OTCMKTS:TPIV), it seems it’s pouring. In yesterday’s session the stock slid in double digits once again. TPIV had slipped down to $0.55 per share by the closing...<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1585],"class_list":["post-6341","post","type-post","status-publish","format-standard","hentry","category-news","tag-tpiv"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/6341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=6341"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/6341\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=6341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=6341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=6341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}